Biochemical Basis of Disease
@SueTayl31355335
Followers
1
Following
120
Statuses
15
RT @matthewcobb: Good news! (Tempted to ask for the vaccine right now...) Features sensible comments from my pal @AndrewJDoig1
https://t.co…
0
3
0
@jiaxin_pei @SarahHBana Thanks Jiaxin for sharing this seminal research. As academics we certainly need to revisit the order in wich we mark exams and assessments. Do you have an idea when your paper will be released?
0
0
0
RT @pulmonaryfibros: The protein MMP19 could be a promising therapeutic target for suppressing pulmonary fibrosis, researchers conclude in…
0
2
0
RT @IPFdoc: Intriguing early report from inhaled Pirfenidone. But we need to wait for final results before drawing conclusions. Inhaled p…
0
6
0
RT @pulmonaryfibros: Immune macrophages and monocytes appeared to be important targets of mesenchymal stem cell treatment in a mouse model…
0
1
0
@peiferlabunc @ExtracellMatrix Hi Mark, a fab opportunity! Thanks for sharing. Is this open to non-USA graduates?
1
0
0
RT @pulmonaryfibros: Carestream and OSIC are partnering in Project OPUS, a new pilot study to uncover X-ray markers that may aid in the ear…
0
1
0
RT @pulmonaryfibros: Rubedo Life Sciences will use the $1.45 million award to develop and study a disease-modifying IPF treatment targeting…
0
2
0
RT @pulmonaryfibros: Bexotegrast at its highest dose was found to improve lung function for patients with idiopathic pulmonary fibrosis in…
0
2
0
RT @pulmonaryfibros: The first patient has been dosed in a Phase 2 trial of bersiporocin, Daewoong’s treatment candidate for idiopathic pul…
0
2
0
RT @PliantRX: #TeamPliant is growing! Join a team committed to advancing novel treatments for fibrotic diseases! Learn about these and othe…
0
1
0
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis
0
0
0
Bexotegrast at its highest dose was found to improve lung function for patients with idiopathic pulmonary fibrosis (IPF) in a Phase 2a trial.
0
0
0